Microbot Medical (MBOT) Research & Development (2010 - 2026)

Microbot Medical (MBOT) has reported Research & Development for 17 consecutive years, with $1.3 million the latest figure, recorded in Q1 2026.

• For the quarter ending Q1 2026, Research & Development fell 11.38% year-over-year to $1.3 million; the trailing twelve-month figure through Mar 2026 stood at $6.1 million (down 11.6% YoY), and the FY2025 full-year result was $6.3 million, down 5.23% from the prior year.
• Research & Development slipped to $1.3 million in Q1 2026 per MBOT's latest filing, from $1.5 million in the prior quarter.
• Across five years, Research & Development topped out at $2.2 million in Q2 2022 and bottomed at $1.1 million in Q4 2023.
• Historically, Research & Development has averaged $1.6 million across 5 years, with a median of $1.6 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Research & Development jumped 75.58% in 2024, then plunged 43.16% in 2025.
• Over 5 years, Research & Development stood at $1.9 million in 2022, then tumbled by 40.02% to $1.1 million in 2023, then surged by 75.58% to $2.0 million in 2024, then dropped by 22.28% to $1.5 million in 2025, then retreated by 16.15% to $1.3 million in 2026.
• According to Business Quant data, Research & Development over the past three periods registered $1.3 million, $1.5 million, and $1.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.